Wells Fargo lowered the firm’s price target on Universal Health to $138 from $154 and keeps an Equal Weight rating on the shares following mixed Q4 results and 2023 guidance below its expectations. While Behavioral fundamentals have shown clear improvement, results in Acute have remained under pressure, Wells notes.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UHS:
- Universal Health price target lowered to $140 from $144 at Mizuho
- Universal Health price target raised to $130 from $114 at RBC Capital
- Universal Health price target lowered to $140 from $155 at Stephens
- Universal Health downgraded to Peer Perform at Wolfe after FY23 guidance
- Universal Health downgraded to Peer Perform from Outperform at Wolfe Research